TASLY(SH:600535) Zheng Quan Zhi Xing·2025-08-15 11:17Summary of Key Points Core Viewpoint - Tianjin Tasly Pharmaceutical Group Co., Ltd. plans to distribute a cash dividend of 2.1 RMB per 10 shares (including tax) to its shareholders based on the total share capital registered on the dividend distribution date [1][2]. Profit Distribution Plan - As of June 30, 2025, the company's available distributable profit is approximately 7.15 billion RMB [1]. - The total share capital of the company is 1,493,950,005 shares, leading to a total cash dividend distribution of approximately 315 million RMB [1]. - The ratio of net profit distributed to shareholders is 40.50% [1]. Decision-Making Process - The company's board of directors held a meeting on August 14, 2025, where the profit distribution plan was unanimously approved with 15 votes in favor [2]. - The profit distribution plan will be submitted for approval at the fourth extraordinary general meeting of shareholders in 2025 [2]. - The supervisory board agrees that the profit distribution plan complies with relevant laws and regulations and considers the company's operational status and future funding needs [2].